Clinical Application and Research Progress of DPP4 Inhibitors in 2 Diabe-tes
Type 2 diabetes mellitus(T2DM)has a high incidence rate in my country and is a common chronic meta-bolic disease in middle-aged and elderly patients.It can involve multiple systems such as the cardiovascular and cere-brovascular systems,endangering life and requiring prompt treatment.Dipeptidyl peptidase-4(DPP4)can promote in-sulin production and secrete glucagon.It is closely related to T2DM and is a new direction in the current research on T2DM treatment in my country.DPP4 inhibitors are the results of multiple studies and can improve the blood glucose-lowering effect and have significant effects on a variety of patients who are ineffective in lowering blood glucose.Based on this,this article mainly reviews the mechanism of action of DPP4 inhibitors in the treatment of T2DM,analyzes the application and research progress of DPP4 inhibitors in T2DM,in order to provide reference for the treatment of T2DM.
NETL
NSTL
万方数据
维普
